Chemoinformaics analysis of Malvidin 3,5-diglucoside
| Molecular Weight | 691.035 | nRot | 9 |
| Heavy Atom Molecular Weight | 655.755 | nRig | 29 |
| Exact Molecular Weight | 690.156 | nRing | 5 |
| Solubility: LogS | -2.301 | nHRing | 3 |
| Solubility: LogP | -0.329 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 2 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 87.5818 |
| nHD | 10 | BPOL | 47.2642 |
| QED | 0.114 |
| Synth | 4.963 |
| Natural Product Likeliness | 1.443 |
| NR-PPAR-gamma | 0.152 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.995 |
| HIA | 0.901 |
| CACO-2 | -6.624 |
| MDCK | 0.0000507 |
| BBB | 0.167 |
| PPB | 0.689765 |
| VDSS | 0.566 |
| FU | 0.300745 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.105 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.178 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.004 |
| CL | 1.647 |
| T12 | 0.842 |
| hERG | 0.403 |
| Ames | 0.251 |
| ROA | 0.004 |
| SkinSen | 0.125 |
| Carcinogencity | 0.023 |
| EI | 0.013 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.712 |
| Antiviral | Yes |
| Prediction | 0.607976 |